Tärnvik A
Department of Infectious Diseases, University of Umeå, Sweden.
Rev Infect Dis. 1989 May-Jun;11(3):440-51.
Tularemia is caused by the facultative intracellular bacterium Francisella tularensis. Attenuated live vaccines, such as F. tularensis LVS (live vaccine strain), afford good--although not complete--protection; how to judge the degree of this protection has long been a problem. Both natural infection and vaccination result in immunospecific and long-lasting humoral and cell-mediated immunity. The latter is the crucial protective mechanism, whereas the humoral response protects only against strains of reduced virulence, such as those used in the vaccines. Immune serum has been used to screen for structures of F. tularensis with the ability to induce a protective immune response. This immune serum is, however, primarily directed toward antigens different from those involved in cell-mediated immunity. Serum antibodies from primed individuals recognize carbohydrate capsule antigens of F. tularensis, whereas T lymphocytes recognize membrane polypeptides of the organism. The preparation of membrane polypeptides from F. tularensis is now facilitated by the availability of a capsule-deficient mutant of F. tularensis LVS. In vitro, several membrane polypeptides of the mutant stimulate T lymphocytes from vaccinees and from naturally infected individuals. Further studies of the mechanisms of induction of protective immunity should focus on these membrane polypeptides.
兔热病由兼性胞内细菌土拉弗朗西斯菌引起。减毒活疫苗,如土拉弗朗西斯菌LVS(活疫苗株),能提供良好的——尽管不是完全的——保护;如何判断这种保护的程度长期以来一直是个问题。自然感染和接种疫苗都会导致免疫特异性和持久的体液免疫及细胞介导免疫。后者是关键的保护机制,而体液反应仅能抵御毒力减弱的菌株,如疫苗中使用的那些菌株。免疫血清已被用于筛选具有诱导保护性免疫反应能力的土拉弗朗西斯菌结构。然而,这种免疫血清主要针对的抗原与细胞介导免疫中涉及的抗原不同。致敏个体的血清抗体识别土拉弗朗西斯菌的碳水化合物荚膜抗原,而T淋巴细胞识别该生物体的膜多肽。现在,由于有了土拉弗朗西斯菌LVS的荚膜缺陷突变体,使得从土拉弗朗西斯菌制备膜多肽变得容易。在体外,该突变体的几种膜多肽能刺激来自接种疫苗者和自然感染者的T淋巴细胞。对保护性免疫诱导机制的进一步研究应聚焦于这些膜多肽。